In the realm of cancer therapy, CAR T cell treatment emerges as an innovative tactic holding considerable potential for individuals grappling with multiple myeloma, a complex hematologic cancer. This novel approach, entailing the manipulation of the patient’s immune cells to bolster their ability to recognize and eliminate cancerous cells, attracts significant attention in China for its specific application in addressing this ailment.
read more..